Today: 1 May 2026
Mastercard stock slides on Trump’s 10% credit-card rate cap talk — what investors watch next
13 January 2026
1 min read

Mastercard stock slides on Trump’s 10% credit-card rate cap talk — what investors watch next

New York, January 12, 2026, 18:42 EST — After-hours

  • Shares of Mastercard slipped 1.6% amid a wider selloff in card-related financial stocks
  • Trump proposed a one-year cap of 10% on credit-card interest rates beginning Jan. 20, offering little detail on the plan
  • Mastercard also highlighted a new open-banking partnership in Australia with cash-flow platform Obol

Mastercard Incorporated shares dipped Monday, pressured by a sell-off in card and consumer finance stocks following President Donald Trump’s call for a one-year cap on credit-card interest rates. The stock last traded down $9.17, or 1.6%, at $566.28, bouncing between $556.20 and $572.00 earlier in the session.

The headline matters because it touches a politically sensitive issue — the cost consumers face to carry balances — just as banks begin their earnings reports and investors search for clues on credit tightening. Mastercard doesn’t set those rates, but it’s at the heart of spending flows, which traders often downgrade when sentiment sours.

On Friday, Trump called for a 10% cap starting Jan. 20 but didn’t specify how card companies would be forced to comply, sending U.S. and UK financial stocks tumbling. J.P. Morgan’s Vivek Juneja argued the cap “would not address the root of the problem and could push consumers towards more expensive debt.” According to a Federal Reserve consumer credit report last week, the average credit-card interest rate in November stood at 20.97%. Reuters

Visa and Mastercard don’t face an immediate earnings hit like banks and issuers who earn interest on revolving balances. The danger is more indirect: if lenders tighten credit lines, reduce rewards, or steer customers to different products, spending could drop—and that means network fees take a hit.

Analysts doubted the White House’s ability to act without Congress. TD Cowen argued that “a card rate cap can only be done by Congress, not executive order,” adding that chances of a federal cap passing remain slim. Reuters

Mastercard announced a partnership with Obol that will enable the cash-flow platform to leverage Mastercard’s open-banking tools as it rolls out in Australia. Brenton Charnley, Mastercard Australasia’s head of open finance, commented, “Open finance is unlocking new opportunities for businesses to better understand and manage their finances.” PR Newswire

Separately, TD Cowen bumped up its price target on Mastercard to $668 from $654, maintaining a buy rating. The firm cited steady fundamentals and ongoing resilience in consumer spending.

Politics can still bog things down. Even if Congress kills a national rate cap, the issue drags consumer finance into the spotlight again. Traders fret the fight could extend to fees, rewards, and other rules that influence card economics.

Tuesday’s bank earnings will be the first test for investors eager to gauge U.S. card spending trends. Meanwhile, markets brace for fresh updates from Washington as the January 20 deadline approaches.

Stock Market Today

  • CAPREIT TSX Dividend Stock Drops 20% Yet Remains a Solid Buy
    April 30, 2026, 10:33 PM EDT. Canadian Apartment Properties REIT (TSX:CAR.UN), known as CAPREIT, has seen its stock price drop nearly 20% from its year-high to $36.78 per unit, with a 4.8% annualized dividend yield paid monthly. Despite the decline, CAPREIT reported stable diluted funds from operations (FFO) of $2.541 in 2025, nearly unchanged from 2024's $2.534, reflecting steady cash flow. The REIT increased its annual dividend distribution to $1.546 per unit with a payout ratio around 60.8%. Revenue and net operating income (NOI) fell due to a $2 billion asset repositioning strategy, focusing on shedding non-core properties for higher-yield assets. Same-property NOI rose 4.7%, and operating margins improved to 64.7%, underscoring operational strength amid market volatility. Investors seeking stable income might consider CAPREIT despite recent price weakness.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
GE Vernova stock pops after $1,087 price-target hike — and Wall Street’s already eyeing Jan. 28
Previous Story

GE Vernova stock pops after $1,087 price-target hike — and Wall Street’s already eyeing Jan. 28

AbbVie stock flat after-hours as TrumpRx pricing deal and RemeGen cancer pact land
Next Story

AbbVie stock flat after-hours as TrumpRx pricing deal and RemeGen cancer pact land

Go toTop